Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for therapeutic drugs
3.2.1.2 Rising prevalence of chronic diseases
3.2.1.3 Growing investment in R&D
3.2.1.4 Rising awareness about food safety
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent government regulations
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product and Services, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.3 Instruments
5.4 Services
Chapter 6 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 LAL test
6.2.1 Chromogenic test
6.2.2 Turbidimetric test
6.2.3 Gel clot test
6.3 In-vitro pyrogen test
6.3.1 Monocyte activation test (MAT)
6.3.2 Recombinant factor C assay (rFC)
6.4 Rabbit test
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical and biotechnology companies
7.3 Medical devices companies
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Almac Group
9.2 bioMérieux SA
9.3 Charles River Laboratories International, Inc.
9.4 Eurofins Scientific
9.5 Fujifilm Holdings Corporation
9.6 GenScript Biotech Corporation
9.7 Lonza
9.8 Merck KGaA
9.9 STERIS plc
9.10 Thermo Fisher Scientific Inc.
